Company profile: Cell Microsystems
1.1 - Company Overview
Company description
- Provider of single-cell biology products, including the CellRaft AIR System for single-cell/colony culture; BioFlux Systems to emulate in vivo shear flow for drug discovery and cell analysis; CERO 3D Incubator & Bioreactor for organoid, spheroid, and tissue research; CASY Cell Counter & Analyzer for cell counting and viability without dyes or reagents; TIGR Tissue Grinder & Dissociator; and IonFlux Mercury Systems for ion channel research.
Products and services
- CellRaft AIR System: An integrated platform for cell culture that grows single cells and colonies with improved viability and clonal outgrowth
- TIGR Tissue Grinder and Dissociator: A semi-automated system that gently mechanically dissociates tissues into single cells, enhancing sample integrity overall
- CASY Cell Counter & Analyzer: Offers accurate, rapid, dye-free cell counting and viability assessment without the need for dyes or reagents
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cell Microsystems
Applied Photophysics
HQ: United Kingdom
Website
- Description: Provider of systems and accessories for the biophysical characterization of biomolecules, offering support and services including Chirascan training, Chirascan system upgrades, Chirascan services, SX training, SX system upgrades, and SX service. Chirascan systems use the phenomenon of circular dichroism (CD).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Applied Photophysics company profile →
MateraCor
HQ: United States
Website
- Description: Provider of trans-catheter myocardial restoration (TCMR) therapy comprising an implantable hydrogel and a minimally invasive endocardial delivery system to treat ischemic or non-ischemic heart failure with reduced ejection fraction (HFrEF), developing novel approaches to prevent progression and reverse heart failure.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MateraCor company profile →
Sepax Technologies
HQ: United States
Website
- Description: Provider of chromatography columns and resins for biomolecule separation and analysis, including ion exchange (Proteomix IEX), hydrophobic interaction (Proteomix HIC Butyl), size exclusion for ADCs and other biomolecules (Monomix MC SEC resins; Zenix-C SEC), reverse phase for DAR analysis (Proteomix RP-1000), and weak cation exchange for monoclonal antibodies (Antibodix WCX), plus method development services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sepax Technologies company profile →
Phenomenex
HQ: United States
Website
- Description: Provider of consumables and analytical chemistry solutions for separation and purification, serving researchers in industrial, clinical research, governmental and academic labs. Offers LC/HPLC columns (Biozen, Kinetex Core-Shell, Luna), GC columns (Zebron), SPE products (Strata-X PRO), and chromatography connectors (SecurityLINK ET) for drug discovery, pharmaceutical development, food safety, and environmental analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phenomenex company profile →
Janvier Labs
HQ: France
Website
- Description: Provider of rodent research models and services, including immunodeficient models for studies in infectious diseases, immune system mechanisms, vaccine development, and cancer immunotherapy; humanized NXG-HIS mice with human-like immune systems for preclinical oncology and immunology; metabolic disease models; aged C57BL/6JRj mice and WISTAR rats; customized genetic model support; and SOPF/SPF colony management and logistics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Janvier Labs company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cell Microsystems
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cell Microsystems
2.2 - Growth funds investing in similar companies to Cell Microsystems
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cell Microsystems
4.2 - Public trading comparable groups for Cell Microsystems
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →